Indivior PLC (OTCMKTS:INVVY – Get Free Report) shares passed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares changing hands.
Indivior Trading Down 1.8%
The business has a 50 day moving average price of $21.85 and a 200-day moving average price of $21.85. The firm has a market capitalization of $3.01 billion, a PE ratio of 20.81 and a beta of 0.35.
Indivior Company Profile
Indivior plc is a specialty pharmaceutical company focused on developing and commercializing medicines for substance use disorders and other behavioral health conditions. Its portfolio includes treatments for opioid use disorder, opioid overdose, alcohol use disorder and schizophrenia.
The company’s products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and tablet formulations; and Opvee, a nalmefene nasal spray designed to reverse opioid overdose.
Recommended Stories
- Five stocks we like better than Indivior
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
